膀胱过度活动症-话题@MedSci

#膀胱过度活动症#

8篇内容 | 819人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2189493, encodeId=af29218949394, content=<a href='/topic/show?id=331e8e782fd' target=_blank style='color:#2F92EE;'>#药物治疗#</a> <a href='/topic/show?id=18b3e120514' target=_blank style='color:#2F92EE;'>#痴呆#</a> <a href='/topic/show?id=4409858114d' target=_blank style='color:#2F92EE;'>#膀胱过度活动症#</a>, objectTitle=Eur Urol Focus：抗胆碱能药物、β-3 激动剂或两者联合治疗膀胱过度活动症后，患者患痴呆症的风险如何？, objectType=article, longId=814898, objectId=d110814898b7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240226/1708940084201_1935437.jpg, objectUrl=/article/show_article.do?id=d110814898b7, replyNumber=0, likeNumber=27, createdTime=2024-02-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d110814898b7, moduleTitle=Eur Urol Focus：抗胆碱能药物、β-3 激动剂或两者联合治疗膀胱过度活动症后，患者患痴呆症的风险如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d110814898b7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1661229, encodeId=a95a166122990, content=<a href='/topic/show?id=4409858114d' target=_blank style='color:#2F92EE;'>#膀胱过度活动症#</a>, objectTitle=Int Urogynecol J：尿液生物标志物在女性膀胱过度活动症诊断中的应用 , objectType=article, longId=215786, objectId=d7c8215e86c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7c8215e86c6, replyNumber=0, likeNumber=53, createdTime=2021-08-24, rootId=0, userName=ms9651749636653578, userId=f8f725235245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7c8215e86c6, moduleTitle=Int Urogynecol J：尿液生物标志物在女性膀胱过度活动症诊断中的应用 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7c8215e86c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661228, encodeId=ed1d1661228df, content=<a href='/topic/show?id=4409858114d' target=_blank style='color:#2F92EE;'>#膀胱过度活动症#</a>, objectTitle=Int J Impot Res：米拉贝隆改善膀胱过度活动症和勃起功能障碍男性的勃起功能, objectType=article, longId=213833, objectId=b005213833d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b005213833d4, replyNumber=0, likeNumber=46, createdTime=2021-12-06, rootId=0, userName=ms9651749636653578, userId=f8f725235245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b005213833d4, moduleTitle=Int J Impot Res：米拉贝隆改善膀胱过度活动症和勃起功能障碍男性的勃起功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b005213833d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661227, encodeId=bd99166122e92, content=<a href='/topic/show?id=4409858114d' target=_blank style='color:#2F92EE;'>#膀胱过度活动症#</a>, objectTitle=AJOG：阴道雌激素治疗绝经后膀胱过度活动症（OAB）, objectType=article, longId=199229, objectId=6bc519922946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bc519922946, replyNumber=0, likeNumber=53, createdTime=2021-04-12, rootId=0, userName=ms9651749636653578, userId=f8f725235245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bc519922946, moduleTitle=AJOG：阴道雌激素治疗绝经后膀胱过度活动症（OAB）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bc519922946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661224, encodeId=126a166122432, content=<a href='/topic/show?id=4409858114d' target=_blank style='color:#2F92EE;'>#膀胱过度活动症#</a>, objectTitle=Urovant Sciences宣布提交Vibegron治疗膀胱过度活动症的新药申请, objectType=article, longId=185516, objectId=c92a18551638, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c92a18551638, replyNumber=0, likeNumber=40, createdTime=2020-02-26, rootId=0, userName=ms9651749636653578, userId=f8f725235245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c92a18551638, moduleTitle=Urovant Sciences宣布提交Vibegron治疗膀胱过度活动症的新药申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c92a18551638)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661225, encodeId=7beb1661225fb, content=<a href='/topic/show?id=4409858114d' target=_blank style='color:#2F92EE;'>#膀胱过度活动症#</a>, objectTitle=基因疗法URO-902治疗膀胱过度活动症：I期临床试验取得积极结果, objectType=article, longId=187516, objectId=50c918e5164f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50c918e5164f, replyNumber=0, likeNumber=43, createdTime=2020-12-02, rootId=0, userName=ms9651749636653578, userId=f8f725235245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50c918e5164f, moduleTitle=基因疗法URO-902治疗膀胱过度活动症：I期临床试验取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50c918e5164f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661226, encodeId=2ee816612269d, content=<a href='/topic/show?id=4409858114d' target=_blank style='color:#2F92EE;'>#膀胱过度活动症#</a>, objectTitle=膀胱过度活动症的治疗取得新进展！FDA接受Vibegron的新药申请（NDA）, objectType=article, longId=189501, objectId=f83118950156, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f83118950156, replyNumber=0, likeNumber=42, createdTime=2021-01-03, rootId=0, userName=ms9651749636653578, userId=f8f725235245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f83118950156, moduleTitle=膀胱过度活动症的治疗取得新进展！FDA接受Vibegron的新药申请（NDA）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f83118950156)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661223, encodeId=50a61661223a5, content=<a href='/topic/show?id=4409858114d' target=_blank style='color:#2F92EE;'>#膀胱过度活动症#</a>, objectTitle=刚刚！总局发布了膀胱过度活动症药物临床试验指导原则, objectType=article, longId=125528, objectId=002e1255283d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=002e1255283d, replyNumber=0, likeNumber=31, createdTime=2018-11-21, rootId=0, userName=ms9651749636653578, userId=f8f725235245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=002e1255283d, moduleTitle=刚刚！总局发布了膀胱过度活动症药物临床试验指导原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=002e1255283d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1661222, encodeId=1b0d16612228b, content=<a href='/topic/show?id=4409858114d' target=_blank style='color:#2F92EE;'>#膀胱过度活动症#</a>, objectTitle=FDA专家小组肯定新药mirabegron治疗膀胱过度活动症效果, objectType=article, longId=5420, objectId=e9df542011, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9df542011, replyNumber=0, likeNumber=46, createdTime=2012-08-19, rootId=0, userName=ms9651749636653578, userId=f8f725235245, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9df542011, moduleTitle=FDA专家小组肯定新药mirabegron治疗膀胱过度活动症效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9df542011)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

膀胱过度活动症

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#药物治疗# #痴呆# #膀胱过度活动症#

Eur Urol Focus：抗胆碱能药物、β-3 激动剂或两者联合治疗膀胱过度活动症后，患者患痴呆症的风险如何？

2024-02-26发表于上海

ms9651749636653578 (审核中...)

前往app查看评论内容

#膀胱过度活动症#

Int Urogynecol J：尿液生物标志物在女性膀胱过度活动症诊断中的应用

2021-08-24

ms9651749636653578 (审核中...)

前往app查看评论内容

#膀胱过度活动症#

Int J Impot Res：米拉贝隆改善膀胱过度活动症和勃起功能障碍男性的勃起功能

2021-12-06

ms9651749636653578 (审核中...)

前往app查看评论内容

#膀胱过度活动症#

AJOG：阴道雌激素治疗绝经后膀胱过度活动症（OAB）

2021-04-12

ms9651749636653578 (审核中...)

前往app查看评论内容

#膀胱过度活动症#

Urovant Sciences宣布提交Vibegron治疗膀胱过度活动症的新药申请

2020-02-26

ms9651749636653578 (审核中...)

前往app查看评论内容

#膀胱过度活动症#

基因疗法URO-902治疗膀胱过度活动症：I期临床试验取得积极结果

2020-12-02

ms9651749636653578 (审核中...)

前往app查看评论内容

#膀胱过度活动症#

膀胱过度活动症的治疗取得新进展！FDA接受Vibegron的新药申请（NDA）

2021-01-03

ms9651749636653578 (审核中...)

前往app查看评论内容

#膀胱过度活动症#

刚刚！总局发布了膀胱过度活动症药物临床试验指导原则

2018-11-21

ms9651749636653578 (审核中...)

前往app查看评论内容

#膀胱过度活动症#

FDA专家小组肯定新药mirabegron治疗膀胱过度活动症效果

2012-08-19

科室
- - 订阅+
  - 更多科室
工具
服务